Wells Fargo & Company »

Cortexyme shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Cortexyme (QNCX) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Cortexyme

Tip: Access up to 7 years of quarterly data

All positions including Cortexyme held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cortexyme by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.3k 1.3k 1.05
2023-09-30 $1.4k 1.2k 1.12
2023-06-30 $232 154 1.51
2022-12-31 $92 145 0.63
2022-09-30 $0 1.3k 0.00
2022-06-30 $3.3k 1.4k 2.38
2022-03-31 $114k 19k 6.17
2021-12-31 $460k 36k 12.64
2021-09-30 $848k 9.9k 85.71
2021-06-30 $709k 12k 57.14
2021-03-31 $425k 12k 35.99
2020-12-31 $879k 32k 27.80
2020-09-30 $806k 16k 51.95
2020-06-30 $877k 19k 47.30
2020-03-31 $723k 16k 45.54
2019-12-31 $765k 14k 56.07
2019-09-30 $202k 8.1k 24.92
2019-06-30 $191k 4.5k 42.53